LIFEVANTAGE CORP Deferred Tax Liabilities, Net
LIFEVANTAGE CORP (LFVN) had Deferred Tax Liabilities, Net of $981.00 thousand as of 2018-06-30, per its 10-K filed 2018-08-15.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilities · last filed 2018-08-15
- 2018-06-30: Deferred Tax Liabilities, Net $981.00K.
- 2017-06-30: Deferred Tax Liabilities, Net $841.00K.
- 2016-06-30: Deferred Tax Liabilities, Net $1.14M.
- 2015-06-30: Deferred Tax Liabilities, Net $1.83M.
| Period end | Deferred Tax Liabilities, Net |
|---|---|
| 2018-06-30 | $981.00K 10-K · filed 2018-08-15 |
| 2017-06-30 | $841.00K 10-K · filed 2018-08-15 |
| 2016-06-30 | $1.14M 10-K · filed 2017-09-07 |
| 2015-06-30 | $1.83M 10-K · filed 2016-12-12 |
| 2014-06-30 | $1.28M 10-K · filed 2015-09-01 |
| 2013-06-30 | $1.66M 10-K · filed 2014-09-10 |
| 2012-06-30 | $1.17M 10-K · filed 2013-09-12 |
| 2011-06-30 | $667.00K 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |